Found: 5
Select item for more details and to access through your institution.
Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 7, p. 1, doi. 10.1007/s00403-024-03122-w
- By:
- Publication type:
- Article
Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 2, p. 535, doi. 10.1007/s13555-022-00870-3
- By:
- Publication type:
- Article
A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial.
- Published in:
- British Journal of Dermatology, 2020, v. 182, n. 6, p. 1348, doi. 10.1111/bjd.18851
- By:
- Publication type:
- Article
Adalimumab Dose Intensification in Recalcitrant Hidradenitis Suppurativa/Acne Inversa.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America.
- Published in:
- 2019
- By:
- Publication type:
- journal article